Compare · ISRG vs ZY
ISRG vs ZY
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and Zymergen Inc. (ZY): market cap, price performance, sector, and recent activity on the wire.
Summary
- ISRG operates in Health Care, while ZY operates in Industrials - the two are in different parts of the market.
- ISRG is the larger of the two at $149.48B, about 306.0x ZY ($488.5M).
- ISRG has hit the wire 7 times in the past 4 weeks while ZY has been quiet.
- ISRG has more recent analyst coverage (25 ratings vs 13 for ZY).
- Company
- Intuitive Surgical Inc.
- Zymergen Inc.
- Price
- $418.56-0.84%
- $2.44+2.10%
- Market cap
- $149.48B
- $488.5M
- 1M return
- -7.66%
- -
- 1Y return
- -20.43%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- 2021
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 13
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Zymergen Inc.
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Latest ISRG
- SVP & GM da Vinci Platforms & Jeddi Iman sold $2,365,594 worth of shares (5,625 units at $420.55) as part of a pre-agreed trading plan and exercised 5,625 shares at a strike of $77.00 (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $15,945 worth of shares (36 units at $442.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,523 units (SEC Form 4)
- SEC Form SD filed by Intuitive Surgical Inc.
- Intuitive Announces Innovations to Advance Quintuple Aim
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $23,464 worth of shares (54 units at $434.52) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,559 units (SEC Form 4)
- EVP & Chief Legal and Complian Loeb Gary sold $178,780 worth of shares (400 units at $446.95) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 6,120 units (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by Director Guthart Gary S
Latest ZY
- SEC Form 15-12G filed by Zymergen Inc.
- SEC Form EFFECT filed by Zymergen Inc.
- SEC Form SC 13G/A filed by Zymergen Inc. (Amendment)
- SEC Form 4: Svf Excalibur (Cayman) Ltd disposed of 26,614,219 shares
- SEC Form 4: Flatley Jay T returned 144,789 shares to the company, closing all direct ownership in the company
- SEC Form 4: Chu Steven returned 50,000 shares to the company, closing all direct ownership in the company
- SEC Form 4: Peterson Sandra E returned 119,119 shares to the company, closing all direct ownership in the company
- SEC Form 4: Murdoch Travis returned 79,697 shares to the company, closing all direct ownership in the company
- SEC Form 4: Gorjanc Christine Marie returned 50,000 shares to the company, closing all direct ownership in the company
- SEC Form 4 filed by Sharma Rohit